Arctic Bioscience AS (ABS.OL)

NOK 1.9

(-5.0%)

Operating Income Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual operating income in 2023 was -48.58 Million NOK , down -29.95% from previous year.
  • Arctic Bioscience AS's latest quarterly operating income in 2024 Q2 was -12.09 Million NOK , down 0.0% from previous quarter.
  • Arctic Bioscience AS reported an annual operating income of -37.38 Million NOK in 2022, down -192.14% from previous year.
  • Arctic Bioscience AS reported an annual operating income of 40.57 Million NOK in 2021, up 287.21% from previous year.
  • Arctic Bioscience AS reported a quarterly operating income of -12.09 Million NOK for 2024 Q1, up 6.99% from previous quarter.
  • Arctic Bioscience AS reported a quarterly operating income of -13 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Operating Income of Arctic Bioscience AS (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -48.58 Million NOK -29.95%
2022 -37.38 Million NOK -192.14%
2021 40.57 Million NOK 287.21%
2020 -21.67 Million NOK -602.93%
2019 -3.08 Million NOK -168.19%
2018 -1.14 Million NOK 0.0%

Peer Operating Income Comparison of Arctic Bioscience AS

Name Operating Income Operating Income Difference
Aqua Bio Technology ASA -17.85 Million NOK -172.082%
ArcticZymes Technologies ASA 15.74 Million NOK 408.562%
BerGenBio ASA -191.81 Million NOK 74.671%
Hofseth BioCare ASA -102.52 Million NOK 52.612%
PCI Biotech Holding ASA -22.24 Million NOK -118.453%
Thor Medical ASA -7.16 Million NOK -578.578%
Ultimovacs ASA -215.73 Million NOK 77.479%